Establishing a murine pancreatic cancer CaSm model: Up-regulation of CaSm is required for the transformed phenotype of murine pancreatic adenocarcinoma

Molecular Therapy

Volumn 11, Issue 3, 2005, Pages 363-372

  Yan, Yan ^a   Rubinchik, Semyon ^a   Watson, Patricia M ^b   Kelley, Joseph R ^a   Fraser, Melissa M ^a   Wood, April L ^a   Dong, Jian Yun ^a   Gillanders, William E ^a   Boylan, Alice M ^b   Watson, Dennis K ^a   Cole, David J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adenovirus; CaSm; Gene therapy; HLsm1; Murine pancreatic cancer model; Oncogene; Pancreatic carcinoma; Plasmids

Indexed keywords

ADENOVIRUS VECTOR; CANCER ASSOCIATED SM LIKE PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

AGAR MEDIUM; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN 3T3; COLONY FORMATION; CONTACT INHIBITION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; MALIGNANT TRANSFORMATION; METASTASIS INHIBITION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PANCREAS ADENOCARCINOMA; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR PROMOTION; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOCARCINOMA; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; MICE; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; TIME FACTORS; UP-REGULATION;

ADENOVIRIDAE; MURINAE;

EID: 14044263017     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.09.023     Document Type: Article

References (37)

1. A. Jemal A. Thomas T. Murray M. Thun Cancer statistics CA J. Cancer, Clin. 52 2002 23-47
2. K.D. Lillemoe C.J. Yeo J.L. Cameron Pancreatic cancer: State-of-the-art care CA J. Cancer, Clin. 50 2000 241-268
3. S.H. Landis T. Murray S. Bolden P.A. Wingo Cancer statistics CA J. Cancer, Clin. 48 1998 6-29
4. S.H. Landis T. Murray S. Bolden P.A. Wingo Cancer statistics CA J. Cancer, Clin. 49 1999 8-31
5. J.J. Huang et al. Quality of life and outcomes after pancreaticoduodenectomy Ann. Surg. 231 2000 890-898
6. M.H. Katz M. Bouvet Novel gene therapy approaches to pancreatic cancer Int. J. Gastrointest. Cancer 33 2003 89-97
7. M. Bouvet et al. Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer Ann. Surg. Oncol. 5 1998 681-688
8. S.E. Kern Advances from genetic clues in pancreatic cancer Curr. Opin. Oncol. 10 1998 74-80
9. K.R. Rogulski et al. In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy Cancer Res. 60 2000 1193-1196
10. M. Takeuchi et al. The dominant negative H-ras mutant, N116Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude mice Gene Ther. 7 2000 518-526
11. D.W. Denham et al. Directed antisense therapy confirms the role of protein kinase C-alpha in the tumorigenicity of pancreatic cancer Surgery 124 1998 218-223
12. W. Friess Collagen-biomaterial for drug delivery Eur. J. Pharm. Biopharm. 45 1998 113-136
13. S. Gansauge et al. The role of anti-p53-autoantibodies in pancreatic disorders Int. J. Pancreatol. 19 1996 171-178
14. K. Aoki T. Yoshida T. Sugimura M. Terada Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity Cancer Res. 55 1995 3810-3816
15. J.M. van Riel G. Giaccone H.M. Pinedo Pancreaticobiliary cancer: The future aspects of medical oncology Ann. Oncol. 10 1999 296-299
16. J. Slavin P. Ghaneh L. Jones R. Sutton M. Hartley J.P. Neoptolemos The future of surgery for pancreatic cancer Ann. Oncol. 10 1999 285-290
17. C.W. Schweinfest M.W. Graber J.M. Chapman T.S. Papas P.L. Baron D.K. Watson CaSm: An Sm-like protein that contributes to the transformed state in cancer cells Cancer Res. 57 1997 2961-2965
18. J. Salgado-Garrido E. Bragado-Nilsson S. Kandels-Lewis B. Seraphin Sm and Sm-like proteins assemble in two related complexes of deep evolutionary origin EMBO J. 18 1999 3451-3462
19. J.R. Kelley et al. The cancer-associated Sm-like oncogene: A novel target for the gene therapy of pancreatic cancer Surgery 128 2000 353-360
20. J.R. Kelley M.M. Fraser C.W. Schweinfest J.N. Vournakis D.K. Watson D.J. Cole CaSm/gemcitabine chemo-gene therapy leads to prolonged survival in a murine model of pancreatic cancer Surgery 130 2001 280-288
21. J.R. Kelley M.M. Fraser J.M. Hubbard D.K. Watson D.J. Cole CaSm antisense gene therapy: A novel approach for the treatment of pancreatic cancer Anticancer Res. 23 2003 2007-2013
22. A.A. Gumbs et al. Overexpression of the Sm-like proto-oncogene in primary and metastatic pancreatic endocrine tumors JOP 3 2002 109-115
23. E.R. Fearon K-ras gene mutation as a pathogenetic and diagnostic marker in human cancer J. Natl. Cancer Inst. 85 1993 1978-1980
24. M.S. Redston et al. p53 mutations in pancreatic carcinoma and evidence of involvement of homocopolymer tracts in DNA microdeletions Cancer Res. 54 1994 3025-3033
25. C.M. Halloran P. Ghaneh J.P. Neoptolemos E. Costello Gene therapy for pancreatic cancer-current and prospective strategies Surg. Oncol. 9 2000 181-191
26. S. Takahashi et al. Down-regulation of Lsm1 is involved in human prostate cancer progression Br. J. Cancer 86 2002 940-946
27. T.H. Corbett et al. Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice Cancer Res. 44 1984 717-726
28. H.G. Burgert Z. Ruzsics S. Obermeier A. Hilgendorf M. Windheim A. Elsing Subversion of host defense mechanisms by adenoviruses Curr. Top. Microbiol. Immunol. 269 2002 273-318
29. D. Wodarz Viruses as antitumor weapons: Defining conditions for tumor remission Cancer Res. 61 2001 3501-3507
30. J. Kucharczak M.J. Simmons Y. Fan C. Gelinas To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis Oncogene 22 2003 8961-8982
31. M.P. Vezeridis G.N. Tzanakakis P.A. Meitner C.M. Doremus L.M. Tibbetts P. Calabresi In vivo selection of a highly metastatic cell line from a human pancreatic carcinoma in the nude mouse Cancer 69 1992 2060-2063
32. A.L. Warshaw C. Fernandez-del Castillo Pancreatic carcinoma N. Engl. J. Med. 326 1992 455-465
33. 32P-labeled single-stranded DNA probes using linear PCR: Application of the method for analysis of strand-specific DNA repair Mutat. Res. 315 1994 189-195
34. Muller, P.Y., Janovjak, H., Miserez, A.R., and Dobbie, Z. (2002). Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32: 1372-1374, 1376, 1378, 1379.
35. C. Nyberg-Hoffman P. Shabram W. Li D. Giroux E. Aguilar-Cordova Sensitivity and reproducibility in adenoviral infectious titer determination Nat. Med. 3 1997 808-811
36. S. Rubinchik J. Woraratanadharm J. Schepp J.Y. Dong Improving the transcriptional regulation of genes delivered by adenovirus vectors Methods Mol. Med. 76 2003 167-199
37. J.V. Maizel Jr. D.O. White M.D. Scharff The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12 Virology 36 1968 115-125